CN Stock MarketDetailed Quotes
300753 Jiangsu Apon Medical Technology
- 18.14
- -1.66-8.38%
Market Closed Jan 10 15:00 CST
2.29BMarket Cap431.90P/E (TTM)
19.99High18.14Low153.97KlotVolume19.61Open19.80Pre Close292.40MTurnover18.68%Turnover Ratio274.85P/E (Static)126.05MShares24.2152wk High3.30P/B1.49BFloat Cap7.9252wk Low23.76Limit Up82.41MShs Float35.93Historical High15.84Limit Down9.34%Amplitude7.92Historical Low0.07Dividend TTM18.99Avg Price87.26KlotAsk0.36%Div YieldTTM100Lot Size61.42KlotBid
Jiangsu Apon Medical Technology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -7.12%274.75M | -4.89%179.47M | -6.71%87.75M | 30.38%422.17M | 37.99%295.81M | 32.24%188.7M | 29.22%94.07M | -29.79%323.81M | -33.88%214.38M | -33.26%142.69M |
| Operating revenue | -7.12%274.75M | -4.89%179.47M | -6.71%87.75M | 30.38%422.17M | 37.99%295.81M | 32.24%188.7M | 29.22%94.07M | -29.79%323.81M | -33.88%214.38M | -33.26%142.69M |
| Other operating revenue | ---- | -51.51%309.84K | ---- | 222.31%1.38M | ---- | 5.35%639.02K | ---- | -12.24%429.59K | ---- | 110.13%606.59K |
| Total operating cost | -7.47%271.03M | -6.94%176.07M | -12.60%86.64M | 1.36%415.6M | 7.27%292.9M | 11.42%189.2M | 15.25%99.12M | -0.44%410.01M | -0.40%273.07M | -1.88%169.8M |
| Operating cost | -20.09%85.11M | -20.39%57.08M | -18.40%29.91M | -11.18%145.45M | 12.11%106.52M | 28.46%71.71M | 19.08%36.66M | -1.55%163.76M | -17.33%95.01M | -25.48%55.82M |
| Operating tax surcharges | 24.72%3.47M | 1.44%1.93M | -15.20%911.64K | 13.75%4.19M | 16.27%2.78M | 17.99%1.9M | 36.93%1.08M | -11.34%3.68M | -19.93%2.39M | -19.03%1.61M |
| Operating expense | 1.36%100.71M | 1.57%59.74M | -21.09%24.77M | 3.58%147.71M | 11.20%99.35M | 1.29%58.81M | 20.72%31.38M | 12.88%142.6M | 33.09%89.35M | 27.87%58.07M |
| Administration expense | 3.97%57.43M | 10.74%40.88M | 14.80%22.77M | 25.27%80.88M | 2.80%55.24M | 9.51%36.92M | 10.45%19.84M | -12.04%64.56M | -19.20%53.73M | -15.63%33.71M |
| Financial expense | 28.87%897.77K | 135.54%697.45K | 24.08%598.88K | 82.60%825.48K | 194.71%696.68K | 148.63%296.11K | 88.17%482.64K | 118.99%452.06K | 76.53%-735.57K | 78.15%-608.93K |
| -Interest expense (Financial expense) | 125.56%2.27M | 9.40%680.83K | 14.78%332.17K | 24.18%3.07M | 178.56%1.01M | 352.23%622.35K | 2,070.47%289.4K | 118.92%2.47M | 13.17%361.13K | -56.87%137.62K |
| -Interest Income (Financial expense) | 13.88%-1.42M | 37.62%-828.64K | 25.59%-199.88K | -10.69%-2.31M | 35.76%-1.65M | 24.39%-1.33M | -14.61%-268.62K | 42.24%-2.08M | 34.58%-2.57M | 46.11%-1.76M |
| Research and development | -17.33%23.41M | -19.55%15.74M | -20.75%7.68M | 4.59%36.55M | -15.02%28.32M | -7.71%19.57M | -5.26%9.69M | -20.54%34.95M | 29.35%33.32M | 56.11%21.2M |
| Credit Impairment Loss | 47.39%-3.11M | 116.10%605.67K | 128.01%1.64M | -710.58%-7.72M | -3.38%-5.91M | 29.19%-3.76M | 156.96%720.21K | 85.87%-952.89K | -5.76%-5.72M | -52.94%-5.31M |
| Asset Impairment Loss | -454.99%-113.6K | 501.32%192.42K | ---- | 97.13%-470.73K | -63.23%32K | -63.23%32K | ---- | -18,745.44%-16.4M | --87.03K | --87.03K |
| Other net revenue | 48.04%9.25M | 75.65%11.97M | -61.77%2.99M | 448.63%7.4M | 51.04%6.25M | 250.90%6.81M | 769.44%7.82M | -133.18%-2.12M | 8.85%4.14M | -17.98%1.94M |
| Invest income | 22.91%-598.29K | -382.22%-535.15K | 132.91%85.12K | -200.76%-1.44M | -157.16%-776.09K | 235.97%189.62K | 61.43%-258.61K | 66.56%1.43M | 59.68%-301.79K | 88.22%-139.46K |
| -Including: Investment income associates | 51.52%-689.71K | -120.53%-646.67K | -58.14%-408.95K | -45.74%-1.18M | -8.70%-1.42M | 61.80%-293.24K | 61.43%-258.61K | 51.62%-812.75K | 22.46%-1.31M | 40.41%-767.6K |
| Asset deal income | 54,641.94%3.64M | 115,890.66%3.53M | ---- | 133.04%6.66K | 114.25%6.66K | 106.51%3.04K | ---- | ---20.15K | ---46.71K | ---46.71K |
| Other revenue | -26.90%9.43M | -20.97%8.18M | -82.84%1.26M | 23.15%17.03M | 27.48%12.9M | 40.78%10.35M | 159.69%7.36M | 11.74%13.82M | 1.62%10.12M | 4.67%7.35M |
| Operating profit | 41.66%12.97M | 143.43%15.37M | 48.33%4.11M | 115.81%13.97M | 116.79%9.16M | 125.08%6.31M | 122.49%2.77M | -258.32%-88.32M | -201.29%-54.55M | -158.38%-25.17M |
| Add:Non operating Income | -98.06%941.14 | -93.25%565.37 | -72.06%838.32 | 26.85%180.83K | -75.13%48.57K | -17.77%8.38K | -99.03%3K | -15.17%142.55K | 3,791.44%195.28K | 103.03%10.19K |
| Less:Non operating expense | 679.61%2.48M | 707.10%2.08M | 1,832.87%2M | -86.61%338.54K | -70.65%317.69K | -73.75%257.55K | -81.33%103.61K | 285.85%2.53M | 211.77%1.08M | 230.38%981.2K |
| Total profit | 18.10%10.5M | 119.16%13.29M | -21.10%2.11M | 115.22%13.81M | 116.04%8.89M | 123.20%6.06M | 121.25%2.67M | -264.03%-90.71M | -203.60%-55.43M | -161.04%-26.14M |
| Less:Income tax cost | 343.35%6.63M | 51.04%4.49M | -31.03%978.15K | 136.72%5.36M | 192.51%1.49M | 509.65%2.97M | 229.01%1.42M | -836.25%-14.59M | -132.07%-1.62M | -113.47%-725.83K |
| Net profit | -47.64%3.87M | 184.70%8.8M | -9.83%1.13M | 111.10%8.45M | 113.74%7.4M | 112.16%3.09M | 110.91%1.25M | -242.76%-76.12M | -211.04%-53.82M | -167.89%-25.41M |
| Net profit from continuing operation | -47.64%3.87M | 184.70%8.8M | -9.83%1.13M | 111.10%8.45M | 113.74%7.4M | 112.16%3.09M | 110.91%1.25M | -242.76%-76.12M | -211.04%-53.82M | -167.89%-25.41M |
| Less:Minority Profit | -89.19%64.59K | -129.76%-95.89K | -762.56%-229.65K | 227.31%172.7K | 137.68%597.54K | 131.44%322.22K | 107.33%34.66K | 81.80%-135.66K | -6,297.58%-1.59M | -516.31%-1.02M |
| Net profit of parent company owners | -43.99%3.81M | 221.31%8.89M | 11.63%1.36M | 110.89%8.28M | 113.01%6.8M | 111.35%2.77M | 111.06%1.22M | -240.54%-75.98M | -207.82%-52.23M | -165.58%-24.39M |
| Earning per share | ||||||||||
| Basic earning per share | -43.97%0.0302 | 220.91%0.0706 | 12.50%0.0108 | 110.90%0.0657 | 113.01%0.0539 | 111.37%0.022 | 111.01%0.0096 | -240.55%-0.6028 | -207.83%-0.4144 | -165.59%-0.1935 |
| Diluted earning per share | -43.97%0.0302 | 220.91%0.0706 | 12.50%0.0108 | 110.90%0.0657 | 113.01%0.0539 | 111.37%0.022 | 111.01%0.0096 | -240.55%-0.6028 | -207.83%-0.4144 | -165.59%-0.1935 |
| Other composite income | ||||||||||
| Total composite income | -47.64%3.87M | 184.70%8.8M | -9.83%1.13M | 111.10%8.45M | 113.74%7.4M | 112.16%3.09M | 110.91%1.25M | -242.76%-76.12M | -211.04%-53.82M | -167.89%-25.41M |
| Total composite income of parent company owners | -43.99%3.81M | 221.31%8.89M | 11.63%1.36M | 110.89%8.28M | 113.01%6.8M | 111.35%2.77M | 111.06%1.22M | -240.54%-75.98M | -207.82%-52.23M | -165.58%-24.39M |
| Total composite income of minority owners | -89.19%64.59K | -129.76%-95.89K | -762.56%-229.65K | 227.31%172.7K | 137.68%597.54K | 131.44%322.22K | 107.33%34.66K | 81.80%-135.66K | -6,297.58%-1.59M | -516.31%-1.02M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
